VERU INC. Deferred Tax Assets, Operating Loss Carryforwards, Foreign
VERU INC. (VERU) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $3.15 million as of 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2025-12-17
- 2025-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $3.15M.
- 2024-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $3.51M; Deferred Tax Assets, Operating Loss Carryforwards, Foreign as first filed $15.30M.
- 2023-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $15.75M.
- 2023-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $16.08M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign as first filed |
|---|---|---|
| 2025-09-30 | $3.15M 10-K · filed 2025-12-17 | |
| 2024-09-30 | $3.51M 10-K · filed 2025-12-17 | $15.30M 10-K · filed 2024-12-16 |
| 2023-09-30 | $15.75M 10-K · filed 2024-12-16 | |
| 2023-06-30 | $16.08M 10-Q/A · filed 2023-11-15 | |
| 2023-03-31 | $16.00M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $15.93M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $15.77M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $15.86M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $15.87M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $15.78M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $15.88M 10-K · filed 2022-12-05 | |
| 2021-06-30 | $15.26M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $11.62M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $11.62M 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $11.66M 10-K · filed 2021-12-02 | |
| 2020-06-30 | $10.60M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $10.62M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $10.58M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $10.49M 10-K · filed 2020-12-10 | |
| 2019-06-30 | $10.63M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $10.62M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $10.60M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $10.60M 10-K · filed 2019-12-12 | |
| 2018-06-30 | $10.58M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $10.69M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $10.58M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $10.58M 10-K · filed 2018-12-13 | |
| 2017-06-30 | $11.21M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $11.20M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $11.06M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $10.96M 10-K · filed 2018-01-02 | |
| 2015-09-30 | $12.39M 10-K · filed 2016-12-12 | |
| 2014-09-30 | $12.57M 10-K · filed 2015-12-02 | |
| 2013-09-30 | $12.65M 10-K · filed 2014-12-02 | |
| 2013-06-30 | $64.26M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $64.26M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $64.26M 10-Q · filed 2013-01-30 | |
| 2012-06-30 | $68.48M 10-Q · filed 2012-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |